Gossamer Bio said it released quarterly results, but this filing does not include the figures or findings. The supplied text gives no clear reason to read the company’s outlook as better or worse.
The attached press release may contain details, but its contents are not included here. Without the figures or findings, this filing gives no clear reason to read Gossamer Bio’s outlook as better or worse.
Follow Gossamer Bio, Inc. (GOSS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GOSS